Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.

Jakacki RI, Bouffet E, Adamson PC, Pollack IF, Ingle AM, Voss SD, Blaney SM.

Neuro Oncol. 2011 Aug;13(8):910-5. doi: 10.1093/neuonc/nor090. Epub 2011 Jul 15.

2.

Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M, Hukin J, Bartels U, Foreman N, Kellie S, Hilden J, Etzl M, Wilson B, Stephens D, Tabori U, Baruchel S.

J Clin Oncol. 2012 Apr 20;30(12):1358-63. doi: 10.1200/JCO.2011.34.5843. Epub 2012 Mar 5.

PMID:
22393086
3.

Phase II study of carboplatin in children with progressive low-grade gliomas.

Gururangan S, Cavazos CM, Ashley D, Herndon JE 2nd, Bruggers CS, Moghrabi A, Scarcella DL, Watral M, Tourt-Uhlig S, Reardon D, Friedman HS.

J Clin Oncol. 2002 Jul 1;20(13):2951-8.

PMID:
12089224
4.

A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.

Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R.

Cancer. 1999 Sep 15;86(6):1064-9.

PMID:
10491535
5.

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.

Masters GA, Hahn EA, Shevrin DH, Kies MS.

Lung Cancer. 2003 Feb;39(2):221-6.

PMID:
12581577
6.

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.

Galanis E, Buckner JC, Maurer MJ, Reid JM, Kuffel MJ, Ames MM, Scheithauer BW, Hammack JE, Pipoly G, Kuross SA.

Invest New Drugs. 2005 Oct;23(5):495-503.

PMID:
16133802
7.

A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.

Robins HI, Chang SM, Prados MD, Yung WK, Hess K, Schiff D, Greenberg H, Fink K, Nicolas K, Kuhn JG, Cloughesy T, Junck L, Mehta M.

Neuro Oncol. 2002 Apr;4(2):109-14.

8.

Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.

Lassaletta A, Scheinemann K, Zelcer SM, Hukin J, Wilson BA, Jabado N, Carret AS, Lafay-Cousin L, Larouche V, Hawkins CE, Pond GR, Poskitt K, Keene D, Johnston DL, Eisenstat DD, Krishnatry R, Mistry M, Arnoldo A, Ramaswamy V, Huang A, Bartels U, Tabori U, Bouffet E.

J Clin Oncol. 2016 Oct 10;34(29):3537-3543. doi: 10.1200/JCO.2016.68.1585.

PMID:
27573663
9.

Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.

Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.

Cancer. 1996 Oct 15;78(8):1701-7.

10.

Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.

Tassinari D, Drudi G, Panzini I, Pasini G, Arcangeli V, Fochessati F, Gianni L, Mianulli AM, Oliverio G, Pasquini E, Sartori S, Ravaioli A.

Int J Clin Oncol. 2001 Dec;6(6):279-83.

PMID:
11828946
11.

Phase I and pharmacokinetic study of IV vinflunine in combination with carboplatin in chemonaive patients with advanced non-small cell lung cancer.

Tournoux-Facon C, Robinet G, Pinel MC, Ferre P, Tourani JM.

Am J Clin Oncol. 2012 Aug;35(4):378-85. doi: 10.1097/COC.0b013e3182143d93.

PMID:
22814308
12.

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators.

Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28.

PMID:
24582486
13.
14.

Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.

Prados MD, Warnick RE, Mack EE, Chandler KL, Rabbitt J, Page M, Malec M.

Am J Clin Oncol. 1996 Dec;19(6):609-12.

PMID:
8931682
15.

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

Gajra A, Mehdi SA, Kirshner J, Newman N, Graziano SL.

Lung Cancer. 2001 May;32(2):189-96.

PMID:
11325490
16.

Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.

Lancaster DL, Hoddes JA, Michalski A.

J Neurooncol. 2003 Jul;63(3):289-94.

PMID:
12892235
17.

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.

Gynecol Oncol. 2005 Jan;96(1):168-72.

PMID:
15589596

Supplemental Content

Support Center